🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies the side effects and best dose of iodine I 131 ...
Status
Terminated
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2003-05
Trial ID
NCT00119366
RATIONALE: Monoclonal antibodies can locate cancer cells and either kill th...
Status
Completed
Location
Fred Hutchinson Cancer Research Center
Start Date
1999-02
Trial ID
NCT00003870
This phase I trial studies the side effects and best dose of iodine I 131 m...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
1999-07-27
Trial ID
NCT00008177
This phase I trial studies the side effects and best dose of iodine I 131 m...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2009-02
Trial ID
NCT00860171
RATIONALE: Radiolabeled monoclonal antibodies can locate cancer cells and e...
Status
Completed
Location
Fred Hutchinson Cancer Research Center
Start Date
1999-02
Trial ID
NCT00003868
This phase II trial studies how well iodine I 131 monoclonal antibody BC8, ...
Status
Completed
Location
Pacific Northwest National Laboratory
Start Date
1999-10
Trial ID
NCT00005940
This phase I trial studies the side effects and best dose of iodine I 131mo...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2007-10-05
Trial ID
NCT00589316